Preliminary research on parent strain XBB has shown that the virus attaches more tightly to human cells than other Omicron variants, such as BA.2.75 and BA.2
The XBB.1.5 variant features a new mutation at the 486 position of the spike, which is the protein the virus uses to bind to the ACE2 receptor protein on cells in the human respiratory tract.predicted that a change in the spike protein at this position would allow a variant to escape previous antibodies. Those predictions seem to be correct.
"Bivalent boosters seem to be working the way they are supposed to," says Suthar, by shifting our immunity towards Omicron variants. He speculates that the bivalent booster would provide some protection against XBB.1.5, based on its similarity to other Omicron variants. But his research also suggests that even the bivalent booster may not block XBB.1.5 breakthrough infections.
"It is difficult to say anything about pathogenicity of XBB.1.5 yet," says Kei Sato, a virologist at the University of Tokyo, since there are no data yet. However, Sato's, not yet peer reviewed, on parent strain XBB has shown that the virus attaches more tightly to human cells than other Omicron variants, such as BA.2.75 and BA.2, which suggests it might cause more severe disease. But when hamsters were infected with XBB, the disease symptoms were no worse than those caused by BA.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
New COVID subvariant XBB.1.5 is 'most transmissible' yetSingapore was hit hard by the new variant, which is very contagious, but the number of hospitalizations didn't rise. – via healthing_ca COVID19 Omicron HealthNews
Consulte Mais informação »
Omicron subvariant XBB.1.5 accounts for 27.6% of U.S. COVID cases - CDCThe Omicron subvariant, XBB.1.5, is estimated to account for 27.6% of COVID-19 cases in the United States for the week ending Jan. 7, data from the Centers for Disease Control and Prevention showed on Friday.
Consulte Mais informação »
U.S. FDA says Evusheld may not protect against Omicron subvariant XBB.1.5The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca's COVID-19 antibody cocktail Evusheld to provide protection against the Omicron subvariant XBB.1.5.
Consulte Mais informação »
Omicron XBB.1.5: What Do We Know So Far?The latest mutation of Omicron could increase COVID-19 cases in the UK but is unlikely to make us sicker, experts said.
Consulte Mais informação »
What to know as new COVID virus variants like XBB.1.5 spread fast across the U.S.New XBB.1.5 variant’s spread has caught the attention of health officials.
Consulte Mais informação »